CYCLOPHARM LIMITED (CYC)

The Company produces and supplies the medical profession with proprietary lung radiopharmaceuticals.

On this page you will find:

Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
CYC	0.200	0%	0.195	0.200	0.000	0.000	0.000	0
(Status - RE)

CYCLOPHARM LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	CYC
Securities	ASX Code, Security Description ------------------------------ CYC, Ordinary Fully Paid
Official Listing Date	18 January, 2007
GICS Industry Group	Health Care Equipment & Services
Exempt Foreign?	No
Internet Address	http://www.cyclopharm.com
Registered Office Address	Building 75, Business & Technology Park, New Illawarra Road, LUCAS HEIGHTS, NSW, AUSTRALIA, 2234
Head Office Telephone	(02) 9541 0411
Head Office Fax	(02) 9543 0960
Share Registry	GOULD RALPH PTY LIMITED LEVEL 42, AAP CENTRE, 259 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone	(02) 9032 3000

Directors / Senior Management
Mr Vanda R Gould (Chairman) Mr James McBrayer (Managing Director) Mr David J Heaney (Non Exec. Director)

Company Secretary	Mr James McBrayer
Principal Activities	The Company produces and supplies the medical profession with proprietary lung radiopharmaceuticals.

CYCLOPHARM LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
15/05/2013		Results of Meeting	3	PDF
15/05/2013		Managing Director's AGM Presentation	24	PDF
15/05/2013		Managing Director's Report	8	PDF
15/05/2013		Chairman's Address to Shareholders	4	PDF
03/05/2013		Change in substantial holding	4	PDF
02/05/2013		Technegas May Facilitate Earlier Diagnosis of COPD	6	PDF
18/04/2013		Cyclopharm Develops New Nuclear Medicine Technology	4	PDF
15/04/2013		Notice of Annual General Meeting/Proxy Form	27	PDF
04/04/2013		Change of Director's Interest Notice	3	PDF
02/04/2013		Form 484 - cancellation of Long Term Incentive Plan shares	2	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
17 May 2013	0.200	0%	0.200	0.200	5,550
16 May 2013	0.200	11.11%	0.200	0.200	3,000
14 May 2013	0.180	0%	0.180	0.180	12,746
07 May 2013	0.180	0%	0.180	0.180	35,233
02 May 2013	0.180	0%	0.180	0.180	1,117

* Volume of shares shown represents only those shares traded on ASX.

CYCLOPHARM LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security CYC. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security CYC

Warrants & Structured Products

No warrants & Structured Products are available over the security CYC

ASX CFDs

No Contracts For Differences are available over the security CYC

MyASX: Login | Sign up